BIKASH PATTNAIK

[BIKASH PATTNAIK @BRPCHANNELS]

Molecular Translator Par Excellence https://t.co/kb8xXN05Tl

[BIKASH PATTNAIK @BRPCHANNELS]

Hear about our CRISPR VISION Program @ARVO2024 representing @SCGE, @UWMadison, @uwpediatrics, @UWDOVS, @BrpChannel

[BIKASH PATTNAIK @BRPCHANNELS]

Get to know our CRISPR VISION program @ARVO2024 on behalf of @somaticediting @BrpChannel @WiscPediatrics @sahakris @WIDiscovery @HoltzCenter @Forward_BIO @UWMadGIE @CMaT_ERC

[BIKASH PATTNAIK @BRPCHANNELS]

Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy https://t.co/CVIV7AyNQE @somaticediting @sophionbio @NIH @diagnosysllc @CRISPR_News @UWMadison @uwsmph @genomicmedicine @FightBlindness

[BIKASH PATTNAIK @BRPCHANNELS]

AOPT next up

[BIKASH PATTNAIK @BRPCHANNELS]

University of Wisconsin-Madison Awarded $29 Million NIH Common Fund Grant to Develop LCA16 and Best Disease Gene-Editing Therapies https://t.co/GJ1zWIIMwt

[BIKASH PATTNAIK @BRPCHANNELS]

Our therapeutic genome editing for a rare pediatric blindness in collaboration with Liu lab @davidrliu @somaticediting @NEIDirector @diagnosysllc
https://t.co/orsInB1hYr

[BIKASH PATTNAIK @BRPCHANNELS]

paris vision institute